Bradycardia Detection on Smartwatches: Accuracy, Thresholds, and Clinical Caveats

Smartwatches can flag low heart rates with reasonable accuracy when perfusion and signal quality are adequate, but apparent bradycardia on PPG is often caused by signal dropouts, cold-induced vasoconstriction, or measurement gaps rather than true conduction disease. Use device-level signal quality, context such as sleep state or medications, and ECG confirmation for clinically actionable bradycardia.

Quick answer for clinicians

• PPG reliably counts slow heart rates at rest if perfusion index and waveform quality meet device thresholds.
• Common false bradycardia causes include sensor dropouts, low perfusion, cold-induced vasoconstriction, and motion-related missed beats.
• Sleep bradycardia is physiological for many people, especially athletes. Distinguish this from pathological bradycardia by symptoms, daytime rates, and ECG correlation.
• Obtain ECG when bradycardia is symptomatic, associated with syncope, or accompanied by pauses or conduction block on device ECG.

How PPG detects slow heart rate and its failure modes

PPG infers beat timing by detecting pulsatile peaks. If the sensor misses pulses because of low signal amplitude or artifact, intervals will appear long, producing apparent bradycardia. The main failure modes are:

• Dropouts. Poor contact, motion, or low perfusion leads to missed beats.
• Low perfusion. Cold extremities or vasoconstriction reduce AC amplitude below detection thresholds.
• Oversmoothing. Aggressive filtering or beat detection that favors stability may undercount beats at the lower end.

For broader context, visit our blog, learn, algorithms, conditions, wearables, and charts hubs.

Sleep bradycardia versus pathologic bradycardia

During sleep there is a normal increase in parasympathetic tone. Heart rates that dip to the 40s or even high 30s can be normal in young, fit individuals. Nocturnal bradycardia without daytime symptoms is often benign. Consider the following to assess clinical significance:

• Symptoms. Daytime syncope, presyncope, or exertional intolerance suggest pathology.
• Daytime rates. Daytime resting rate under 50 bpm in an older adult on negative chronotropic drugs is more concerning.
• Pauses and AV block. PPG cannot reliably distinguish pauses due to sinus arrest from missed beats. ECG is required to confirm conduction abnormalities.

If nocturnal bradycardia is asymptomatic and isolated, document and reassure. If there are pauses, symptoms, or daytime bradycardia, proceed to ECG monitoring.

Dropouts and cold-induced vasoconstriction: the common traps

1. Dropouts. When the watch loses good skin contact you will see flat lines or transient absence of pulse. The algorithm may interpolate or simply show a long interval. Look at the raw waveform or device SQI to confirm.
2. Cold exposure. Peripheral vasoconstriction reduces the AC amplitude and increases the chance of missed beats. This is common in outdoor activities in cold weather or in patients with Raynaud phenomenon.
3. Compression. Tight straps or external pressure can alter readings similar to low perfusion.

Practical rule: always inspect signal quality metadata if an alert for severe bradycardia arrives without symptoms.

When should a smartwatch bradycardia alert prompt ECG?

Obtain ECG confirmation in these circumstances:

• Syncope, near syncope, confusion, or other concerning symptoms.
• Bradycardia with hemodynamic instability or heart failure exacerbation.
• Recurrent long pauses or repetitive slow episodes captured by device ECG.
• New bradycardia in the setting of beta blocker or antiarrhythmic toxicity, or after initiation of AV nodal blocking agents.

ECG capture options

• If the watch supports a single-lead ECG, ask the patient to record an ECG at the time of symptoms and forward it.
• If events are intermittent, consider a 14-day ambulatory patch or event monitor.
• For unexplained syncope with suspected conduction disease, consider inpatient telemetry or an implantable loop recorder depending on event frequency and risk.

Threshold choices and their tradeoffs

A single absolute cutoff such as HR under 50 bpm is simple but not always appropriate. Thresholds should consider age, activity, medications, and clinical context.

• Conservative threshold: HR under 40 bpm or symptomatic bradycardia. This reduces false alarms but risks missing significant slow rates in older or medicated patients.
• Sensitive threshold: HR under 50 bpm or any sudden drop greater than 20 percent from baseline. This increases sensitivity but causes more false positives from dropouts.

Combine thresholds with SQI gating and time-of-day rules to maximize actionability.

Interpreting device ECGs for bradyarrhythmia

Single-lead ECGs from smartwatches can identify sinus bradycardia, pauses, and sometimes AV block. They are less reliable for detailed conduction system analysis than 12-lead ECG or telemetry, but they are valuable when correlated with symptoms.

Tips for clinicians

• Request timestamped ECGs and the PPG trace when possible.
• Inspect for regularity, P waves preceding each QRS if visible, and consistent PR intervals when evaluating for AV block.
• Be cautious with automated classifications. Have a clinician review unusual tracings.

Clinical workflow recommendations

• Triage rules should combine HR threshold, SQI, symptoms, and daytime versus nighttime context.
• Provide patient guidance: if symptomatic with slow heart rate, seek urgent care. If asymptomatic and the watch shows isolated nocturnal dips, document and observe.
• Educate users on proper wear: snug but not tight, warm wrist in cold environments, and periodic cleaning of the optical sensor area.

Case vignette

A 72-year-old on metoprolol receives a nighttime alert of HR 35 bpm. He feels well in the morning but reports fatigue over two weeks. The watch SQI for the event was low, and the PPG trace shows amplitude attenuation. A supervised 12-lead ECG in clinic showed sinus bradycardia at 52 bpm with Mobitz type I block. Ambulatory monitoring captured intermittent second-degree AV block with symptoms. The patient was evaluated for medication adjustment and underwent electrophysiology consultation.

Special populations and equity concerns

• Athletes. Resting and nocturnal bradycardia may be normal. Interpret with training history.
• Older adults. Lower reserve and more frequent conduction disease require a lower threshold for ECG confirmation.
• Peripheral vascular disease and diabetes. Reduced perfusion increases false negative risk.
• Skin tone. Algorithms validated on narrow skin tone cohorts may underperform in darker skin. Ensure diverse validation.

FAQs

Is a smartwatch good at detecting heart block?

It can detect pauses and some AV block patterns on single-lead ECG, but diagnosis of complex conduction disease needs a 12-lead ECG or telemetry.

Can cold weather cause false bradycardia alerts?

Yes. Cold-induced vasoconstriction reduces signal amplitude and can lead to missed beats that look like bradycardia.

How should I counsel a patient with nocturnal bradycardia but no symptoms?

Reassure if isolated. Consider daytime ECG and record symptoms. If episodes are frequent or the patient is on AV nodal blockers, consider ambulatory monitoring.

When is an implantable loop recorder indicated?

Consider ILR when syncope is unexplained and suspected arrhythmic pauses are infrequent but clinically significant. Use device alerts as adjunctive data, not sole justification.

Do smartwatches miss bradycardia in peripheral vascular disease?

They can miss events due to low perfusion. Use ECG-based monitoring or alternative sensor sites when needed.

References

• Caillol T, Strik M, Ramirez FD, et al. Accuracy of a Smartwatch-Derived ECG for Diagnosing Bradyarrhythmias, Tachyarrhythmias, and Cardiac Ischemia. Circ Arrhythm Electrophysiol. 2021;14:e009260. doi:10.1161/CIRCEP.120.009260
• Elgendi M. On the analysis of fingertip photoplethysmogram signals. Curr Cardiol Rev. 2012;8(1):14-25. doi:10.2174/157340312801215782
• Nazarian S, Lam K, Darzi A, Ashrafian H. Diagnostic Accuracy of Smartwatches for the Detection of Cardiac Arrhythmia: Systematic Review and Meta-analysis. J Med Internet Res. 2021;23(8):e28974. doi:10.2196/28974